In 2023, the Vitamin D Testing market size is anticipated to be worth US$ 917.55 million. The market is predicted to develop at an 8.1% CAGR to reach US$ 1,999.35 million by 2033, according to Future Market Insights.
Vitamin D testing kits have become much more precise and useful as technology has advanced. These assays, which require only a little blood sample, are widely accessible and may accurately assess the body’s vitamin D levels. Because of the development of immunoassay-based technologies that can discriminate between vitamin D2 and D3 forms, the use of Vitamin D Testing kits has expanded.
Technology has made it possible to test vitamin levels at home. With the advent of new technology, it is now possible to develop quick Vitamin D Testing that is both very reliable and simple to use at home. The combination of growing awareness of the importance of vitamin D and the availability of accurate quick vitamin D testing is largely responsible for the favourable market forecast.
Identify key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. View our PDF Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16906
Efforts by the government and the private sector to raise awareness of vitamin D deficiency are improving public understanding of vitamin D. Its nutritional benefits and utilisation of Vitamin D Testing processes are boosting the industry even further. Horlicks Women’s Plus and Apollo Clinic, for example, teamed together in January 2022 to improve women’s awareness of bone health.
Key Takeaways
- In 2018, China expanded in the Vitamin D Testing industry with a market value of US$ 38.4 billion. In 2023, the market is anticipated to be worth $74.9 million.
- The Vitamin D Testing market was rapidly developing, with a projected value of $848.8 billion in 2022.
- As a result of increasing cloud-based platforms, the market is expected to reach a valuation of US$ 1,159.08 million by 2026.
- Analysts estimate it will rise 1.08 times between 2022 and 2023 due to the market’s high potential and use of smartphones in testing.
- As demand for preventive healthcare solutions grows, the market in the United Kingdom is predicted to expand at a rapid pace by 2033.
- Based on product type, the 25-hydroxy vitamin D test dominated the market in 2022 and continued to lead the market during the forecast period.
- Based on indications, osteoporosis led the market in 2022 and continues to lead the market during the forecast period.
- The LC-MS segment dominated the market in 2022 and is likely to hold the top spot throughout the projected period.
- Based on patient category, adult patients led the market in 2022 and continues to lead during the forecast period
Avail Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-16906
Critical Approaches Increasing Top Players’ Wealth
Due to a few dominant competitors controlling the bulk of market shares, the Vitamin D Testing industry is consolidated in nature. One of the primary reasons for market dominance is the development of cutting-edge modern technologies that give patients precise outcomes.
Recent Developments
- In order to increase the presence of its brand, Thermo Fisher Scientific Inc. made declared in March 2020. The Cascadion SM Clinical Analyzer for the Cascadion SM 25-hydroxy vitamin D assay is now offered in the United States.
- In January 2022, F. Hoffmann-La Roche Ltd. released Cobas Infinity Edge. It is a cloud-based platform for integrating and managing point-of-care data that can be used in clinical settings anywhere in the world.
Key Players
- Abbott
- F. Hoffmann-La Roche Ltd
- BIOMÉRIEUX
- Thermo Fisher Scientific Inc.
- Danaher
- Siemens Healthineers AG
- DiaSorin S.p.A.
- Beckman Coulter, Inc. (BD)
- Tosoh Bioscience, Inc.
- Quest Diagnostics Incorporated.
Expand operations in the future – To get requisite details, ask for a custom report@ https://www.futuremarketinsights.com/customization-available/rep-gb-16906
Key Segments
Vitamin D Testing By Product:
- 25-Hydroxy Vitamin D Testing
- 1,25-Dihydroxy Vitamin D Testing
Vitamin D Testing by Indication:
- Vitamin D Testing for Osteoporosis
- Vitamin D Testing for Rickets
- Vitamin D Testing for Thyroid Disorders
- Vitamin D Testing for Vitamin D Deficiency
- Others
Vitamin D Testing by Technology:
- Radioimmunoassay
- ELISA
- HPLC
- LC-MS
- Others
Vitamin D Testing by Patient:
- Vitamin D Testing in Adult
- Vitamin D Testing in Pediatric
Vitamin D Testing by Test Location:
- Vitamin D Testing at Point-of-Care
- Others
Vitamin D Testing by End-use:
- Vitamin D Testing for Hospitals
- Vitamin D Testing for Diagnostic Laboratories
- Vitamin D Testing for Homecare
- Others
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
